References
- Chan RW, Wong J, Chan HL, et al (2010). Aberrant concentrations of liver-derived plasma albumin mRNA in liver pathologies. Clin Chem 56:82–9
- Fleischhacker M. (2006). Biology of circulating mRNA: still more questions than answers? Ann N Y Acad Sci 1075:40–9.
- Fournie GJ, Courtin JP, Laval F, et al. (1995). Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours. Cancer Lett 91:221–7
- Giesen PL, Peltenburg HG, de Zwaan C, et al. (1989). Greater than expected alanine aminotransferase activities in plasma and in hearts of patients with acute myocardial infarction. Clin Chem 35:279–83
- Jahr S, Hentze H, Englisch S, et al. (2001). DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 61:1659–65
- Kudo Y, Ochi T, Shimada H, et al. (2008). Utility of plasma circulating mRNA as a marker to detect hepatic injury. J Vet Med Sci 70:993–5
- Laird ME, Mohsen A, Duffy D, et al. (2014). Apolipoprotein H expression is associated with IL28B genotype and viral clearance in hepatitis C virus infection. J Hepatol 61:770–6
- Laterza OF, Lim L, Garrett-Engele PW, et al. (2009). Plasma microRNAs as sensitive and specific biomarkers of tissue injury. Clin Chem 55:1977–83
- Leise MD, Poterucha JJ, Talwalkar JA. (2014). Drug-induced liver injury. Mayo Clin Proc 89:95–106
- Ma TC, Shao HB, Xu Y, Xu K. (2013). Three treatment methods via the hepatic artery for hepatocellular carcinoma – a retrospective study. Asian Pac J Cancer Prev 14:2491–4
- Mathivanan S, Ji H, Simpson RJ. (2010). Exosomes: extracellular organelles important in intercellular communication. J Proteomics 73:1907–20
- Melkonyan HS, Feaver WJ, Meyer E, et al. (2008). Transrenal nucleic acids: from proof of principle to clinical tests. Ann N Y Acad Sci 1137:73–81
- Miura N, Nakamura H, Sato R, et al. (2006). Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer. Cancer Sci 97:1366–73
- Miyamoto M, Yanai M, Ookubo S, et al. (2008). Detection of cell-free, liver-specific mRNAs in peripheral blood from rats with hepatotoxicity: a potential toxicological biomarker for safety evaluation. Toxicol Sci 106:538–45
- Nathwani RA, Pais S, Reynolds TB, Kaplowitz N. (2005). Serum alanine aminotransferase in skeletal muscle diseases. Hepatology 41:380–2
- Nosaka K. (1996). Changes in serum enzyme activities after injection of bupivacaine into rat tibialis anterior. J Appl Physiol 81:876–84
- Okubo S, Miyamoto M, Takami K, et al. (2013). Identification of novel liver-specific mRNAs in plasma for biomarkers of drug-induced liver injury and quantitative evaluation in rats treated with various hepatotoxic compounds. Toxicol Sci 132:21–31
- Schwarzenbach H. (2013). Circulating nucleic acids as biomarkers in breast cancer. Breast Cancer Res 15:211
- Seldinger SI. (1953). Catheter replacement of the needle in percutaneous arteriography: a new technique. Acta Radiol 39:368–76
- Shao RX, Hoshida Y, Otsuka M, et al. (2005). Hepatic gene expression profiles associated with fibrosis progression and hepatocarcinogenesis in hepatitis C patients. World J Gastroenterol 11:1995–9
- Sita-Lumsden A, Fletcher CE, Dart DA, et al. (2013). Circulating nucleic acids as biomarkers of prostate cancer. Biomark Med 7:867–77
- Starkey Lewis PJ, Dear J, Platt V, et al. (2011). Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology 54:1767–76
- Swaminathan R, Butt AN. (2006). Circulating nucleic acids in plasma and serum: recent developments. Ann N Y Acad Sci 1075:1–9
- Swarup V, Rajeswari MR. (2007). Circulating (cell-free) nucleic acids – a promising, non-invasive tool for early detection of several human diseases. FEBS Lett 581:795–9
- Wang K, Zhang S, Marzolf B, et al. (2009). Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci USA 106:4402–7
- Wetmore BA, Brees DJ, Singh R, et al. (2010). Quantitative analyses and transcriptomic profiling of circulating messenger RNAs as biomarkers of rat liver injury. Hepatology 51:2127–39
- Wong IH, Lau WY, Leung T, Johnson PJ. (2000). Quantitative comparison of alpha-fetoprotein and albumin mRNA levels in hepatocellular carcinoma/adenoma, non-tumor liver and blood: implications in cancer detection and monitoring. Cancer Lett 156:141–9
- Zhang X, Zhang Z, Dai F, et al. (2014). Comparison of circulating, hepatocyte specific messenger RNA and microRNA as biomarkers for chronic hepatitis B and C. PLoS One 9:e92112
- Zhang Y, Jia Y, Zheng R, et al. (2010). Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. Clin Chem 56:1830–8